CIK 0001661059
- Non-accelerated filer
- Smaller reporting company
NextCure, Inc.
Sign in to watch- Ticker
- NXTC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 475231247
- Phone
- +1 240-399-4900
- Business address
- 2850 QUARRY LAKE DRIVE, SUITE 280, BALTIMORE, MD, 21209
- Open-market buys, last 90 days
- $140,487
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$140,487. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-22 | Nicholson Garry A Director | Grant or award · Stock Option (Right to Buy) | +14,250 | 14,250 | ||
| 2022-06-23 | Nicholson Garry A Director | Grant or award · Stock Option (Right to Buy) | +14,250 | 14,250 | ||
| 2021-06-24 | Nicholson Garry A Director | Grant or award · Stock Option (Right to Buy) | +14,250 | 14,250 | ||
| 2020-06-11 | Nicholson Garry A Director | Grant or award · Stock Option (Right to Buy) | +16,083 | 16,083 | ||
| 2020-06-11 | Nicholson Garry A Director | Grant or award · Stock Option (Right to Buy) | +28,500 | 28,500 |
Page 1 of 1 · 5 trades